Resistance in trans-ition

J Thorac Oncol. 2017 Nov;12(11):1608-1610. doi: 10.1016/j.jtho.2017.09.1953.

Authors

Natalie I Vokes¹, Pasi A Jänne²

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: pasi_janne@dfci.harvard.edu.

PMID: 29074207
DOI: 10.1016/j.jtho.2017.09.1953

No abstract available

Publication types

Editorial
Comment

MeSH terms

ErbB Receptors / genetics*
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / genetics*

Substances

EGFR protein, human
ErbB Receptors

Grants and funding

T32 CA009172/CA/NCI NIH HHS/United States